Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKaryopharm Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Karyopharm Therapeutics Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

Loading earnings…

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
QuarterRevenue YoYGross marginCash & equivalents
QuarterRevenue YoYGross marginCash & equivalents
(Filed on August 13, 2026)
-11.9%100.0%$55M

Generation was interrupted. Revisit the company page to retry.

(Filed on May 14, 2026)
+16.8%100.0%$90.9M

Generation was interrupted. Revisit the company page to retry.

(Filed on February 13, 2026)
+11.6%100.0%$60.5M

Generation was interrupted. Revisit the company page to retry.

(Filed on November 3, 2025)
+13.6%100.0%$37.7M

Generation was interrupted. Revisit the company page to retry.

(Filed on August 13, 2026)
-11.4%100.0%$38.7M
(Filed on May 14, 2026)
-9.4%100.0%$38.8M
(Filed on February 13, 2026)
-9.5%100.0%$62.5M
(Filed on November 3, 2025)
+7.7%100.0%$72.8M
(Filed on August 11, 2025)
+13.9%100.0%$84.8M
(Filed on May 12, 2025)
-14.4%100.0%$30.6M
(Filed on February 19, 2025)
+0.5%100.0%$52.2M
(Filed on November 5, 2024)
-0.4%100.0%$43.7M
(Filed on August 6, 2024)
-5.3%100.0%$80.9M
(Filed on May 8, 2024)
-18.8%100.0%$84.1M
(Filed on February 29, 2024)
-73.4%100.0%$135.2M
(Filed on November 2, 2023)
-4.1%100.0%$71.4M
(Filed on August 2, 2023)
+75.6%100.0%$82.2M
(Filed on May 4, 2023)
+104.9%100.0%$153.3M
(Filed on February 17, 2023)
+259.7%100.0%$190.5M
(Filed on November 3, 2022)
+76.7%100.0%$137.4M
(Filed on August 4, 2022)
-32.6%100.0%$141.3M
(Filed on May 5, 2022)
+28.2%100.0%$88.5M
(Filed on March 1, 2022)
+94.0%100.0%$85.9M
(Filed on November 3, 2021)
+62.2%100.0%$82.3M
(Filed on August 5, 2021)
+253.0%100.0%$103.1M
(Filed on May 4, 2021)
+11,601.9%100.0%$202.2M
(Filed on February 24, 2021)
+8,684.5%100.0%$128.9M
(Filed on November 2, 2020)
+5,401.7%92.3%$168M
(Filed on August 4, 2020)
-52.3%100.0%$75.5M
(Filed on May 5, 2020)
-98.5%100.0%$83.5M
(Filed on February 26, 2020)
-86.6%100.0%$118M
(Filed on November 4, 2019)
—100.0%$101.6M
(Filed on August 7, 2019)
+662,933.3%100.0%$119M
(Filed on May 9, 2019)
+14,605.9%100.0%$37.5M
(Filed on February 28, 2019)
+3,163.8%100.0%$69M
(Filed on November 8, 2018)
——$54.5M
(Filed on August 7, 2018)
-94.9%100.0%$55.4M
(Filed on May 10, 2018)
—100.0%$25.6M
(Filed on March 15, 2018)
+88.0%100.0%$49.7M
(Filed on November 2, 2017)
-36.0%100.0%$43.9M
(Filed on August 8, 2017)
-60.7%100.0%$37.7M
(Filed on May 4, 2017)
——$42.2M
(Filed on March 16, 2017)
+66.7%100.0%$58.4M
(Filed on November 7, 2016)
+257.1%100.0%$43.5M
(Filed on August 4, 2016)
+614.3%100.0%$24.2M
(Filed on May 9, 2016)
——$51.5M
(Filed on March 15, 2016)
-28.6%100.0%$150.6M
(Filed on November 9, 2015)
—100.0%$227.1M
(Filed on August 10, 2015)
-84.2%100.0%$132.3M
(Filed on May 11, 2015)
-26.6%100.0%$144.9M
(Filed on March 13, 2015)
-36.4%100.0%$156M
(Filed on November 10, 2014)
——$52.9M
(Filed on August 7, 2014)
-75.0%100.0%—
(Filed on May 8, 2014)
+585.3%100.0%—
(Filed on March 21, 2014)
—100.0%$391K
(Filed on December 23, 2013)
—100.0%—